ciltacabtagene autoleucel
janssen,legend bio
dr. jes s san-miguel introduced clinical data regarding the efficacy and safety of cilta-cel in pts with progressive mm. responses were favorable and these initial results may inform treatment plans, including sequencing and washout periods between agents targeting bcma. #ims2022 
To cure myeloma by fostering research, education and excellence in clinical care worldwide.